These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 13432033)

  • 1. Clinical report of a new hypoglycemic agent.
    POMERANZE J; FUJIY H; MOURATOFF GT
    Proc Soc Exp Biol Med; 1957 May; 95(1):193-4. PubMed ID: 13432033
    [No Abstract]   [Full Text] [Related]  

  • 2. [Management of diabetes mellitus with hypoglycemic urea derivatives].
    MOHNIKE G
    Dtsch Gesundheitsw; 1956 Sep; 11(38):1293-4. PubMed ID: 13375186
    [No Abstract]   [Full Text] [Related]  

  • 3. Early clinical evaluation of a new oral non-sulfonylurea hypoglycemic agent.
    KRALL LP; CAMERINI-DAVALOS R
    Proc Soc Exp Biol Med; 1957 Jun; 95(2):345-7. PubMed ID: 13441732
    [No Abstract]   [Full Text] [Related]  

  • 4. [Introduction of new peroral hypoglycemic drugs for the ambulant treatment of diabetes mellitus].
    STRATMANN FW
    Medizinische; 1956 Sep; 24(36):1253-7. PubMed ID: 13377930
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experiences in diabetes therapy with hypoglycemic sulfonamide compounds].
    BREDNOW W; JORKE D
    Munch Med Wochenschr; 1957 Jan; 99(4):101-5. PubMed ID: 13407645
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of diabetes mellitus with hypoglycemic sulfonamides].
    BOULIN R
    Gaz Med Fr; 1957 Mar; 64(6):545-53. PubMed ID: 13427960
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral hypoglycemic agents for treatment of diabetes mellitus.
    HACKEDORN HM
    Northwest Med; 1956 Sep; 55(9):965-7. PubMed ID: 13358973
    [No Abstract]   [Full Text] [Related]  

  • 8. [Oral treatment of diabetes mellitus with D-860, a new hypoglycemic but not sulfonamidic drug; clinical study of 90 cases].
    INTROZZI P; MARIGO S
    Prog Med (Napoli); 1956 Sep; 12(17):513-27. PubMed ID: 13379550
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experiences with carbutamide, an orally given hypoglycemic agent; preliminary report.
    RIDOLFO AS; KIRTLEY WR
    J Am Med Assoc; 1956 Apr; 160(15):1285-8. PubMed ID: 13306540
    [No Abstract]   [Full Text] [Related]  

  • 10. The relation of various variables to the hypoglycemic action of 1-butyl-3-p-tolylsulfonylurea in patients with diabetes mellitus.
    DIENGOTT D; DOLGER H; MIRSKY IA
    Metabolism; 1956 Nov; 5(6 Part 2):875-93. PubMed ID: 13378057
    [No Abstract]   [Full Text] [Related]  

  • 11. Progress report of American Diabetes Association on orally effective hypoglycemic sulfonylureas.
    COLWELL AR; INGLE D; KRAHL ME; LEVINE R; RICKETTS HT
    J Am Med Assoc; 1956 Nov; 162(10):976-7. PubMed ID: 13366694
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of ten cases of diabetes with oral hypoglycemic sulfonamide BZ 55 or nadisan].
    FERNANDEZ BASABE E; GALAN J; OLIVER A; OLIVER-PASCUAL E; PURAS E
    Rev Esp Enferm Apar Dig Nutr; 1956; 15(2):478-88. PubMed ID: 13370980
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypoglycemic action of sulfonylureas in patients with diabetes mellitus.
    MIRSKY IA; DIENGOTT D; DOLGER H
    Science; 1956 Apr; 123(3197):583-4. PubMed ID: 13311504
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypoglycaemic sulphonamides in the management of diabetes mellitus.
    DOWNIE E; BORNSTEIN J; HUDSON B
    Australas Ann Med; 1957 May; 6(2):105-12. PubMed ID: 13445634
    [No Abstract]   [Full Text] [Related]  

  • 15. CURRENT investigation of the hypoglycemic action of sulfonylureas.
    Nutr Rev; 1957 May; 15(5):150-1. PubMed ID: 13431090
    [No Abstract]   [Full Text] [Related]  

  • 16. [Findings in the course of antidiabetic treatment with 1-para-aminobenzenesulfonyl-3-N-butyl urea].
    MORSIANI M; SERRAVALLI S
    Arcisp S Anna Ferrara; 1956; 9(4):747-59. PubMed ID: 13382613
    [No Abstract]   [Full Text] [Related]  

  • 17. [Severe hypoglycemic reactions during peroral treatment of diabetes with N1-sulfanilyl-n-2-n-butylcarbamid (BZ 55)].
    BENDFELDT E; OTTO H
    Munch Med Wochenschr; 1956 Aug; 98(35):1136-7. PubMed ID: 13369451
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trial of the new oral hypoglycaemic agent BZ 55.
    HUNT JA; OAKLEY W; LAWRENCE RD
    Br Med J; 1956 Aug; 2(4990):445-8. PubMed ID: 13342509
    [No Abstract]   [Full Text] [Related]  

  • 19. [The antidiabetic action of BZ 55 in clinical experience].
    BELTRAMETTI L; ZAMPORI O
    G Clin Med; 1956 Sep; 37(9):1249-64. PubMed ID: 13384741
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of a hypoglycemic sulfonamide derivative (BZ 55) on the effectiveness of insulin in diabetics].
    BARTELHEIMER H; MARING H
    Klin Wochenschr; 1956 Oct; 34(37-38):1011-6. PubMed ID: 13377627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.